{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:33:03Z","timestamp":1791289983162,"version":"4.3.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1681\/asn.2011121213","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:06:27Z","timestamp":1343952387000},"page":"1691-1700","source":"Crossref","is-referenced-by-count":96,"title":["Npt2b Deletion Attenuates Hyperphosphatemia Associated with CKD"],"prefix":"10.1681","volume":"23","author":[{"given":"Susan C.","family":"Schiavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Arbeeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20230208","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"R2-16-20230208","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study.","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R3-16-20230208","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1139\/o61-048","article-title":"Progress and rate of absorption of radiophosphorus through the intestinal tract of rats.","volume":"39","author":"Cramer","year":"1961","journal-title":"Can J Biochem Physiol"},{"key":"R4-16-20230208","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI116313","article-title":"Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach.","volume":"91","author":"Kayne","year":"1993","journal-title":"J Clin Invest"},{"key":"R5-16-20230208","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1113\/expphysiol.1956.sp001211","article-title":"The absorption of inorganic phosphate from the small intestine of the rat","volume":"41","author":"McHardy","year":"1956","journal-title":"Q J Exp Physiol"},{"key":"R6-16-20230208","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis.","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R7-16-20230208","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.ki.5000258","article-title":"Extended release nicotinic acid is a promising agent for phosphate control in hemodialysis.","volume":"69","author":"Sampathkumar","year":"2006","journal-title":"Kidney Int"},{"key":"R8-16-20230208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11255-007-9306-7","article-title":"Hyperphosphatemia and nicotinic acid in peritoneal dialysis patients.","volume":"40","author":"Musso","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"R9-16-20230208","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","article-title":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients.","volume":"65","author":"Takahashi","year":"2004","journal-title":"Kidney Int"},{"key":"R10-16-20230208","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-16-20230208","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","article-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine.","volume":"14","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R12-16-20230208","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","article-title":"Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure.","volume":"20","author":"Eto","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R13-16-20230208","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ki.2011.159","article-title":"Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.","volume":"80","author":"Caldas","year":"2011","journal-title":"Kidney Int"},{"key":"R14-16-20230208","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1152\/ajprenal.00126.2009","article-title":"Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.","volume":"297","author":"Cho","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-16-20230208","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.ki.5002292","article-title":"Intestinal phosphate absorption in a model of chronic renal failure.","volume":"72","author":"Marks","year":"2007","journal-title":"Kidney Int"},{"key":"R17-16-20230208","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/jbmr.485","article-title":"The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.","volume":"26","author":"Moe","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R18-16-20230208","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate.","volume":"297","author":"Giral","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R19-16-20230208","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semnephrol.2009.01.008","article-title":"The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: The links between bone and the vasculature.","volume":"29","author":"Hruska","year":"2009","journal-title":"Semin Nephrol"},{"key":"R20-16-20230208","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: Out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R21-16-20230208","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R22-16-20230208","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1523-1755.2005.00171.x","article-title":"Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration.","volume":"67","author":"Lacour","year":"2005","journal-title":"Kidney Int"},{"key":"R23-16-20230208","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"R24-16-20230208","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R25-16-20230208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"R26-16-20230208","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"R27-16-20230208","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R28-16-20230208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: A new conceptual framework for the interpretation of bone histomorphometry.","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R31-16-20230208","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease.","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"R32-16-20230208","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2003.05.002","article-title":"Misconceptions (3): Calcium leaves bone only by resorption and enters only by formation.","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone"},{"key":"R33-16-20230208","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification\u2014results from the BRiC study.","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"R34-16-20230208","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R35-16-20230208","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1210\/en.2008-0205","article-title":"Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats.","volume":"149","author":"Sampath","year":"2008","journal-title":"Endocrinology"},{"key":"R36-16-20230208","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/en.2005-0671","article-title":"Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts.","volume":"147","author":"Koyama","year":"2006","journal-title":"Endocrinology"},{"key":"R37-16-20230208","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1359\/jbmr.070709","article-title":"Regulation of osteoclast differentiation and function by phosphate: Potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.","volume":"22","author":"Hayashibara","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R38-16-20230208","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jbmr.294","article-title":"Unique roles of phosphorus in endochondral bone formation and osteocyte maturation.","volume":"26","author":"Zhang","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R40-16-20230208","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R41-16-20230208","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R42-16-20230208","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/ndt\/gfm094","article-title":"Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice.","volume":"22","author":"Westenfeld","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R43-16-20230208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00272702","article-title":"A reproducible model for chronic renal failure in the mouse.","volume":"11","author":"Gagnon","year":"1983","journal-title":"Urol Res"},{"key":"R44-16-20230208","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units.","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201210000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:06Z","timestamp":1786130526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201210000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2011121213","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}